November 25, 2018
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
July 29, 2018
resTORbio, ADMA Biologics, Misonix, Novus Therapeutics and Innovate Biopharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
July 15, 2018
Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
July 3, 2018
Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...
April 30, 2018
Pharmaceutical and biotech companies in the US must follow a standard process to advance a new drug candidate through nonclinical...
April 29, 2018
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 18, 2018
With Q1 2018 behind us, here the Investing News Network looks back on some of the biggest trends of the...